Glaukos Announces Participation in the Citi Healthcare Conference

by Business Wire • 2023/02/15 • 0 Comments

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Citi Healthcare Conference on Wednesday, March 1, 2023, at 1:15 p.m. ET in New York City. A live and archived webcast for this event will be available in the Investors section of the Glaukos website

← Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023

Harrow Launches Next-Generation Compounded Atropine Formulations →

Post navigation